Methylated ctDNA is being actively investigated as a substrate for cancer diagnostic blood tests (reviewed in Warton & Samimi (2015)), and a blood test for colorectal cancer based on SEPT9 methylation is currently under review by the FDA. Here, SEPTIN9 is linked to colorectal cancer.